tetano
Editor, Senior Moderator
Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Oct 6;53(10):1043-1048. doi: 10.3760/cma.j.issn.0253-9624.2019.10.017. [h=1][A systematic review of the economic burden of influenza in China].[/h]
[Article in Chinese; Abstract available in Chinese from the publisher]
Zhu AQ[SUP]1[/SUP], Zheng YM[SUP]1[/SUP], Qin Y[SUP]1[/SUP], Liu SS[SUP]2[/SUP], Cui JZ[SUP]1[/SUP], Li ZL[SUP]1[/SUP], Li S[SUP]3[/SUP], Feng LZ[SUP]1[/SUP], Li ZJ[SUP]1[/SUP].
[h=3]Author information[/h] 1 Division of Infectious Disease, Key Laboratory of Infectious Disease Surveillance and Ear-warning, Chinese Center for Disease Control and Prevention, Beijing 102206, China. 2 School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China. 3 Changping District Center for Disease Control and Prevention, Beijing 102200, China.
[h=3]Abstract[/h] in English, Chinese
Objectives: To understand the status of studies about influenza economic burden in mainland China and summarize their major results. Methods: The words of influenza, flu, cost, economic, burden, effectiveness, benefit, utility, China, and Chinese, were used as search keywords. Journal papers published during 2000-2018 were searched from Chinese electronic databases (CNKI and Wanfang) and English electronic databases (PubMed, Web of science, EconLit and Cochrane Library). The language of literature was restricted to Chinese and English. A total of 23 effective documents were included, and the descriptive characteristics, research indexes and methods included in the literature were analyzed. The monetary unit used in this review is Chinese Yuan (CNY). Results: The 23 study sites were mainly in the relatively developed and populous regions. The total cost per capita of laboratory-confirmed influenza,of all age-group was reported in 6 literatures, and only 4 literatures reported it in out-patients (range: 768.0-999.9 CNY), Only one study reported this indicator in inpatients (9 832.0 CNY). One literature reported the total cost per capita of influenza-like illness,, which was 205.1 CNY. And one literature reported that the direct medical cost of inpatients per capita in children under 5 years of age was 6 072.0 CNY while two literature reported this index for the elderly over 60 years of age, ranging from 14 250.0 to 19 349.1 CNY. Four articles reported the economic burden of influenza in urban and rural areas, one of which showed that the related expenses of urban influenza inpatients accounted for 31% of the average annual income, while which for the rural flow was 113%. Conclusion: The average economic burden of lab-confirmed influenza case is higher than that of influenza-like illness, and there are differences in outpatient indirect expenses and inpatients direct medical expenses. The direct medical burden for the hospitalized 60-years-and-beyond influenza case group is heavier thar other age group. By region, the influenza associated individual economic burden in rural area is higher than that of urban area..
[h=4]KEYWORDS:[/h] Economic burden; Fees, medical; Influenza, human; Systematic Review
PMID: 31607053 DOI: 10.3760/cma.j.issn.0253-9624.2019.10.017
[Indexed for MEDLINE]
[Article in Chinese; Abstract available in Chinese from the publisher]
Zhu AQ[SUP]1[/SUP], Zheng YM[SUP]1[/SUP], Qin Y[SUP]1[/SUP], Liu SS[SUP]2[/SUP], Cui JZ[SUP]1[/SUP], Li ZL[SUP]1[/SUP], Li S[SUP]3[/SUP], Feng LZ[SUP]1[/SUP], Li ZJ[SUP]1[/SUP].
[h=3]Author information[/h] 1 Division of Infectious Disease, Key Laboratory of Infectious Disease Surveillance and Ear-warning, Chinese Center for Disease Control and Prevention, Beijing 102206, China. 2 School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China. 3 Changping District Center for Disease Control and Prevention, Beijing 102200, China.
[h=3]Abstract[/h] in English, Chinese
Objectives: To understand the status of studies about influenza economic burden in mainland China and summarize their major results. Methods: The words of influenza, flu, cost, economic, burden, effectiveness, benefit, utility, China, and Chinese, were used as search keywords. Journal papers published during 2000-2018 were searched from Chinese electronic databases (CNKI and Wanfang) and English electronic databases (PubMed, Web of science, EconLit and Cochrane Library). The language of literature was restricted to Chinese and English. A total of 23 effective documents were included, and the descriptive characteristics, research indexes and methods included in the literature were analyzed. The monetary unit used in this review is Chinese Yuan (CNY). Results: The 23 study sites were mainly in the relatively developed and populous regions. The total cost per capita of laboratory-confirmed influenza,of all age-group was reported in 6 literatures, and only 4 literatures reported it in out-patients (range: 768.0-999.9 CNY), Only one study reported this indicator in inpatients (9 832.0 CNY). One literature reported the total cost per capita of influenza-like illness,, which was 205.1 CNY. And one literature reported that the direct medical cost of inpatients per capita in children under 5 years of age was 6 072.0 CNY while two literature reported this index for the elderly over 60 years of age, ranging from 14 250.0 to 19 349.1 CNY. Four articles reported the economic burden of influenza in urban and rural areas, one of which showed that the related expenses of urban influenza inpatients accounted for 31% of the average annual income, while which for the rural flow was 113%. Conclusion: The average economic burden of lab-confirmed influenza case is higher than that of influenza-like illness, and there are differences in outpatient indirect expenses and inpatients direct medical expenses. The direct medical burden for the hospitalized 60-years-and-beyond influenza case group is heavier thar other age group. By region, the influenza associated individual economic burden in rural area is higher than that of urban area..
[h=4]KEYWORDS:[/h] Economic burden; Fees, medical; Influenza, human; Systematic Review
PMID: 31607053 DOI: 10.3760/cma.j.issn.0253-9624.2019.10.017
[Indexed for MEDLINE]